It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ulcerative colitis and Crohn’s disease are chronic inflammatory intestinal diseases with perplexing heterogeneity in disease manifestation and response to treatment. While the molecular basis for this heterogeneity remains uncharacterized, single-cell technologies allow us to explore the transcriptional states within tissues at an unprecedented resolution which could further understanding of these complex diseases. Here, we apply single-cell RNA-sequencing to human inflamed intestine and show that the largest differences among patients are present within the myeloid compartment including macrophages and neutrophils. Using spatial transcriptomics in human tissue at single-cell resolution (CosMx Spatial Molecular Imaging) we spatially localize each of the macrophage and neutrophil subsets identified by single-cell RNA-sequencing and unravel further macrophage diversity based on their tissue localization. Finally, single-cell RNA-sequencing combined with single-cell spatial analysis reveals a strong communication network involving macrophages and inflammatory fibroblasts. Our data sheds light on the cellular complexity of these diseases and points towards the myeloid and stromal compartments as important cellular subsets for understanding patient-to-patient heterogeneity.
Chronic intestinal inflammatory diseases including ulcerative colitis and Crohn’s disease display extensive heterogeneity in the immunopathology, disease manifestation and response to treatment. Here the authors apply single cell transcriptomic and spatial molecular imaging, and characterise macrophage and neutrophils in samples from patients with inflammatory bowel diseases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Inflammatory Bowel Disease Unit, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain (GRID:grid.10403.36) (ISNI:0000000091771775); Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain (GRID:grid.452371.6) (ISNI:0000 0004 5930 4607)
2 Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain (GRID:grid.429289.c)
3 University of Zurich, Switzerland. SIB Swiss Institute of Bioinformatics, Department of Molecular Life Sciences, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
4 Consejo Superior de Investigaciones Científicas (CSIC), Centro de Investigaciones Biológicas, Madrid, Spain (GRID:grid.4711.3) (ISNI:0000 0001 2183 4846)
5 NanoString Technologies, Seattle, USA (GRID:grid.510973.9) (ISNI:0000 0004 5375 2863)
6 Boehringer-Ingelheim Pharmaceuticals Inc, Translational Medicine and Clinical Pharmacology, Ridgefield, USA (GRID:grid.418412.a) (ISNI:0000 0001 1312 9717)
7 Barcelona Institute of Science and Technology (BIST), CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona, Spain (GRID:grid.11478.3b)
8 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain (GRID:grid.452371.6) (ISNI:0000 0004 5930 4607); Hospital Universitari Mútua Terrassa, Universitat de Barcelona, Department of Gastroenterology, Terrassa, Spain (GRID:grid.414875.b) (ISNI:0000 0004 1794 4956)
9 Barcelona Institute of Science and Technology (BIST), CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona, Spain (GRID:grid.11478.3b); Universitat Pompeu Fabra (UPF), Barcelona, Spain (GRID:grid.5612.0) (ISNI:0000 0001 2172 2676)